Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| At Risk Persons | 1 |
| Attention Deficit… | 1 |
| Children | 1 |
| Correlation | 1 |
| Drug Therapy | 1 |
| Heart Disorders | 1 |
| Identification | 1 |
| Metabolism | 1 |
| Patients | 1 |
| Stimulants | 1 |
| More ▼ | |
Source
| Journal of the American… | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkHammerness, Paul G.; Perrin, James M.; Shelley-Abrahamson, Rachel; Wilens, Timothy E. – Journal of the American Academy of Child & Adolescent Psychiatry, 2011
Objective: This review provides an update on the cardiovascular impact of therapeutic stimulant-class medication for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Method: Relevant clinical literature was ascertained using PubMed searches limited to human studies and the English language as of May 2011. Current…
Descriptors: Attention Deficit Hyperactivity Disorder, Metabolism, Stimulants, Adolescents
